Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/8948
Title: | Possible involvement of phosphatidylinositol 3 kinase in experimental vascular endothelium dysfunction |
Researcher: | Sharma, Saurabh |
Guide(s): | Manjeet Singh |
Keywords: | pharmacy vascular endothelium Endothelial Endothelial Phenotypes |
Upload Date: | 17-May-2013 |
University: | Punjab Technical University |
Completed Date: | 2012 |
Abstract: | Vascular endothelium plays a role in capillary transport of nutrients and drugs and regulates angiogenesis, homeostasis, as well as vascular tone and permeability As a major regulator of local vascular homeostasis, the endothelium maintains the balance between vasodilatation and vasoconstriction, procoagulant and anticoagulant, prothrombotic and antithrombotic mechanisms. Diabetes mellitus causes the activation of aldose reductase, polyol pathway and advanced glycation-end-product formation that collectively affect the phosphorylation status and expression of endothelial nitric oxide synthatase (eNOS) and causes vascular endothelium dysfunction. Elevated homocysteine levels have been associated with increase in LDL oxidation, generation of hydrogen peroxides, superoxide anions that increased oxidative degradation of nitric oxide. Hyperhomocysteinemia has been reported to increase the endogenous competitive inhibitors of eNOS viz- L-N-monomethyl arginine (L-NMMA) and asymmetric dimethyl arginine (ADMA) that may contribute to vascular endothelial dysfunction. Hypercholesterolemia stimulates oxidation of LDL-cholesterol, release of endothelins, and generation of ROS. The increased cholesterol and triglyceride level and decreased protective HDL level, decreases the activity and expression of eNOS and disrupts the integrity of vascular endothelium, due to oxidative stress. Hypertension also stimulates release of endothelins, vasoconstrictor prostanoids, angiotensin II, inflammatory cytokines, xanthine oxidase and, thereby, reduces bioavailability of nitric oxide. Thus, the cellular and molecular mechanisms underlying diabetes mellitus, hyperhomocysteinemia, hypercholestrolemmia and hypertension leads to animbalance of phosphorylation and dephosphorylation status of lipid and protein kinase that cause modulation of vascular endothelial L-arginine/nitric oxide synthetase (eNOS), to produce vascular endothelium dysfunction. |
Pagination: | 145p. |
URI: | http://hdl.handle.net/10603/8948 |
Appears in Departments: | Department of Pharmacy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
01_title.pdf | Attached File | 104.73 kB | Adobe PDF | View/Open |
02_dedication.pdf | 284.44 kB | Adobe PDF | View/Open | |
03_declaration.pdf | 89.84 kB | Adobe PDF | View/Open | |
04_acknowledgement.pdf | 71.15 kB | Adobe PDF | View/Open | |
05_abstract.pdf | 69.42 kB | Adobe PDF | View/Open | |
06_table of contents.pdf | 39.62 kB | Adobe PDF | View/Open | |
07_list of abbreviations.pdf | 39.48 kB | Adobe PDF | View/Open | |
08_list of figures.pdf | 71.63 kB | Adobe PDF | View/Open | |
09_list of publications.pdf | 75.63 kB | Adobe PDF | View/Open | |
10_chapter 1.pdf | 47.82 kB | Adobe PDF | View/Open | |
11_chapter 2.pdf | 46.34 kB | Adobe PDF | View/Open | |
12_chapter 3.pdf | 409.7 kB | Adobe PDF | View/Open | |
13_chapter 4.pdf | 159.63 kB | Adobe PDF | View/Open | |
14_chapter 5.pdf | 1.84 MB | Adobe PDF | View/Open | |
15_chapter 6.pdf | 841.83 kB | Adobe PDF | View/Open | |
16_chapter 7.pdf | 57.43 kB | Adobe PDF | View/Open | |
17_chapter 8.pdf | 12.09 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Altmetric Badge: